Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

BIOLOGICALS AND HEMATOPOIETIC CYTOKINES IN PREVENTION OR TREATMENT OF INFECTIONS IN IMMUNOCOMPROMISED HOSTS HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA Roilides, E., Pizzo, P. A. 1993; 7 (4): 841-864

Abstract

The number of immunocompromised hosts has dramatically increased in recent years. The primary reason for this increase has been the intensification of antineoplastic therapy for the treatment of various malignancies and the explosive spread of human immunodeficiency virus infection. Although the treatment and prevention of many infections have been improved with the rational use of antimicrobial agents, ultimate success can be blunted by protracted impairment of essential host defenses or by the virulence of certain organisms.

View details for Web of Science ID A1993LN53600006

View details for PubMedID 7689074